US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 2.850
  • +0.140+5.17%
Close Dec 20 16:00 ET
  • 2.800
  • -0.050-1.75%
Post 20:01 ET
841.79MMarket Cap-4.67P/E (TTM)

AbCellera Biologics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-27,147.17%-28.88M
-250.56%-29.97M
5.34%-41.71M
-115.82%-43.88M
-163.44%-19.61M
99.92%-106K
-92.71%19.9M
-143.97%-44.06M
13.40%277.36M
284.97%30.91M
Net income from continuing operations
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
3.29%158.52M
-149.86%-29.89M
Depreciation and amortization
416.87%38.3M
424.21%38.04M
-4.97%6.77M
-6.67%30.89M
-40.70%9.11M
10.12%7.41M
20.11%7.26M
43.17%7.12M
91.90%33.1M
215.85%15.36M
Deferred tax
----
----
----
192.72%1.96M
--8.31M
----
----
----
-4.76%-2.11M
----
Other non cash items
---9.61M
-5,034.59%-40.82M
146.97%1.71M
-190.57%-7.74M
----
----
-370.41%-795K
-513.85%-3.63M
139.41%8.55M
-11.87%5.24M
Change In working capital
-180.04%-5.73M
-129.14%-8.04M
-17.75%-26.98M
-55.66%13.23M
-95.14%1.41M
104.08%7.16M
-89.45%27.57M
73.05%-22.91M
-28.43%29.83M
130.68%28.99M
-Change in receivables
-76.79%-19.82M
50.73%-15.86M
-208.16%-18.58M
-134.44%-36.66M
-115.78%-10.44M
81.10%-11.21M
-111.65%-32.18M
109.72%17.18M
373.60%106.46M
148.11%66.17M
-Change in payables and accrued expense
-79.46%1.39M
-94.86%1.98M
76.74%-8.06M
-621.30%-15.1M
-166.41%-25.68M
105.69%6.78M
353.71%38.45M
-137.02%-34.65M
35.31%-2.09M
-27.28%38.68M
-Change in other current assets
-72.89%2.48M
73.33%2.13M
40.54%-3.61M
753.09%8.98M
3,228.19%4.66M
214.18%9.15M
-64.01%1.23M
19.77%-6.06M
59.33%-1.38M
-136.88%-149K
-Change in other working capital
318.42%10.22M
-81.50%3.71M
425.97%3.26M
176.55%56.01M
143.42%32.87M
2,141.28%2.44M
728.16%20.08M
-88.97%620K
-383.44%-73.16M
-616.63%-75.7M
Cash from discontinued investing activities
Operating cash flow
-27,147.17%-28.88M
-250.56%-29.97M
5.34%-41.71M
-115.82%-43.88M
-163.44%-19.61M
99.92%-106K
-92.71%19.9M
-143.97%-44.06M
13.40%277.36M
284.97%30.91M
Investing cash flow
Cash flow from continuing investing activities
128.92%3.7M
251.49%52.1M
119.99%29.91M
37.30%-221.11M
-42.55%-24.32M
95.47%-12.79M
-26.45%-34.39M
-467.32%-149.61M
-6.13%-352.63M
-1,385.03%-17.06M
Net PPE purchase and sale
8.93%-18.52M
26.07%-20.11M
-61.11%-24.14M
-8.90%-76.95M
-17.04%-14.43M
-62.48%-20.33M
13.16%-27.2M
-3.37%-14.98M
-20.89%-70.66M
-30.75%-12.33M
Net intangibles purchase and sale
----
----
----
72.00%-560K
----
----
----
----
---2M
--0
Net business purchase and sale
-101.52%-7.14M
-122.91%-4.91M
-32.18%-5.91M
46.69%-13.69M
41.17%-3.48M
13.13%-3.54M
70.05%-2.2M
46.38%-4.47M
38.54%-25.68M
-83.62%-5.91M
Net investment purchase and sale
431.15%19.95M
746.36%64.54M
139.74%52.79M
42.66%-155.22M
-1,294.13%-16.14M
101.39%3.76M
-266.92%-9.99M
-2,064.72%-132.85M
-2.30%-270.72M
89.77%-1.16M
Net other investing changes
28.24%9.4M
151.64%12.58M
166.17%7.17M
54.02%25.31M
340.79%10.29M
22.13%7.33M
-9.12%5M
3.74%2.69M
-49.62%16.43M
-89.77%2.33M
Cash from discontinued investing activities
Investing cash flow
128.92%3.7M
251.49%52.1M
119.99%29.91M
37.30%-221.11M
-42.55%-24.32M
95.47%-12.79M
-26.45%-34.39M
-467.32%-149.61M
-6.13%-352.63M
-1,385.03%-17.06M
Financing cash flow
Cash flow from continuing financing activities
-52.56%3.15M
532.70%2.65M
718.12%2.83M
736.12%10.36M
978.80%3.77M
34,994.74%6.63M
-64.28%419K
85.37%-458K
58.11%-1.63M
-80.97%349K
Net issuance payments of debt
----
----
----
320.69%11.59M
----
----
----
----
-49.79%2.76M
-96.46%349K
Proceeds from stock option exercised by employees
-11.33%227K
38.02%461K
82.04%892K
----
----
--256K
--334K
--490K
----
----
Net other financing activities
-54.22%2.92M
2,476.47%2.19M
304.54%1.94M
71.85%-1.23M
---6.75M
2,649.60%6.37M
-90.95%85K
81.31%-948K
53.24%-4.38M
--0
Cash from discontinued financing activities
Financing cash flow
-52.56%3.15M
532.70%2.65M
718.12%2.83M
736.12%10.36M
978.80%3.77M
34,994.74%6.63M
-64.28%419K
85.37%-458K
58.11%-1.63M
-80.97%349K
Net cash flow
Beginning cash position
-15.18%175.6M
-31.52%150.86M
-61.27%160.61M
-17.26%414.65M
-50.08%199.71M
-74.67%207.04M
-61.46%220.31M
-17.26%414.65M
-15.65%501.14M
-22.72%400.09M
Current changes in cash
-251.95%-22.04M
276.17%24.78M
95.38%-8.97M
-231.15%-254.63M
-382.92%-40.17M
98.47%-6.26M
-105.70%-14.07M
-374.52%-194.13M
16.01%-76.89M
188.59%14.2M
Effect of exchange rate changes
134.52%367K
-105.40%-43K
-266.67%-781K
106.14%589K
193.41%1.07M
87.57%-1.06M
166.03%797K
-4.41%-213K
-573.61%-9.6M
169.33%364K
End cash Position
-22.92%153.93M
-15.18%175.6M
-31.52%150.86M
-61.27%160.61M
-61.27%160.61M
-50.08%199.71M
-74.67%207.04M
-61.46%220.31M
-17.26%414.65M
-17.26%414.65M
Free cash flow
-131.92%-47.4M
-586.16%-50.08M
-11.52%-65.85M
-159.30%-121.38M
-286.21%-34.6M
85.54%-20.44M
-103.02%-7.3M
-168.88%-59.05M
9.98%204.7M
171.08%18.58M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -27,147.17%-28.88M-250.56%-29.97M5.34%-41.71M-115.82%-43.88M-163.44%-19.61M99.92%-106K-92.71%19.9M-143.97%-44.06M13.40%277.36M284.97%30.91M
Net income from continuing operations -78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M-207.46%-28.61M-349.93%-30.53M-123.79%-40.11M3.29%158.52M-149.86%-29.89M
Depreciation and amortization 416.87%38.3M424.21%38.04M-4.97%6.77M-6.67%30.89M-40.70%9.11M10.12%7.41M20.11%7.26M43.17%7.12M91.90%33.1M215.85%15.36M
Deferred tax ------------192.72%1.96M--8.31M-------------4.76%-2.11M----
Other non cash items ---9.61M-5,034.59%-40.82M146.97%1.71M-190.57%-7.74M---------370.41%-795K-513.85%-3.63M139.41%8.55M-11.87%5.24M
Change In working capital -180.04%-5.73M-129.14%-8.04M-17.75%-26.98M-55.66%13.23M-95.14%1.41M104.08%7.16M-89.45%27.57M73.05%-22.91M-28.43%29.83M130.68%28.99M
-Change in receivables -76.79%-19.82M50.73%-15.86M-208.16%-18.58M-134.44%-36.66M-115.78%-10.44M81.10%-11.21M-111.65%-32.18M109.72%17.18M373.60%106.46M148.11%66.17M
-Change in payables and accrued expense -79.46%1.39M-94.86%1.98M76.74%-8.06M-621.30%-15.1M-166.41%-25.68M105.69%6.78M353.71%38.45M-137.02%-34.65M35.31%-2.09M-27.28%38.68M
-Change in other current assets -72.89%2.48M73.33%2.13M40.54%-3.61M753.09%8.98M3,228.19%4.66M214.18%9.15M-64.01%1.23M19.77%-6.06M59.33%-1.38M-136.88%-149K
-Change in other working capital 318.42%10.22M-81.50%3.71M425.97%3.26M176.55%56.01M143.42%32.87M2,141.28%2.44M728.16%20.08M-88.97%620K-383.44%-73.16M-616.63%-75.7M
Cash from discontinued investing activities
Operating cash flow -27,147.17%-28.88M-250.56%-29.97M5.34%-41.71M-115.82%-43.88M-163.44%-19.61M99.92%-106K-92.71%19.9M-143.97%-44.06M13.40%277.36M284.97%30.91M
Investing cash flow
Cash flow from continuing investing activities 128.92%3.7M251.49%52.1M119.99%29.91M37.30%-221.11M-42.55%-24.32M95.47%-12.79M-26.45%-34.39M-467.32%-149.61M-6.13%-352.63M-1,385.03%-17.06M
Net PPE purchase and sale 8.93%-18.52M26.07%-20.11M-61.11%-24.14M-8.90%-76.95M-17.04%-14.43M-62.48%-20.33M13.16%-27.2M-3.37%-14.98M-20.89%-70.66M-30.75%-12.33M
Net intangibles purchase and sale ------------72.00%-560K-------------------2M--0
Net business purchase and sale -101.52%-7.14M-122.91%-4.91M-32.18%-5.91M46.69%-13.69M41.17%-3.48M13.13%-3.54M70.05%-2.2M46.38%-4.47M38.54%-25.68M-83.62%-5.91M
Net investment purchase and sale 431.15%19.95M746.36%64.54M139.74%52.79M42.66%-155.22M-1,294.13%-16.14M101.39%3.76M-266.92%-9.99M-2,064.72%-132.85M-2.30%-270.72M89.77%-1.16M
Net other investing changes 28.24%9.4M151.64%12.58M166.17%7.17M54.02%25.31M340.79%10.29M22.13%7.33M-9.12%5M3.74%2.69M-49.62%16.43M-89.77%2.33M
Cash from discontinued investing activities
Investing cash flow 128.92%3.7M251.49%52.1M119.99%29.91M37.30%-221.11M-42.55%-24.32M95.47%-12.79M-26.45%-34.39M-467.32%-149.61M-6.13%-352.63M-1,385.03%-17.06M
Financing cash flow
Cash flow from continuing financing activities -52.56%3.15M532.70%2.65M718.12%2.83M736.12%10.36M978.80%3.77M34,994.74%6.63M-64.28%419K85.37%-458K58.11%-1.63M-80.97%349K
Net issuance payments of debt ------------320.69%11.59M-----------------49.79%2.76M-96.46%349K
Proceeds from stock option exercised by employees -11.33%227K38.02%461K82.04%892K----------256K--334K--490K--------
Net other financing activities -54.22%2.92M2,476.47%2.19M304.54%1.94M71.85%-1.23M---6.75M2,649.60%6.37M-90.95%85K81.31%-948K53.24%-4.38M--0
Cash from discontinued financing activities
Financing cash flow -52.56%3.15M532.70%2.65M718.12%2.83M736.12%10.36M978.80%3.77M34,994.74%6.63M-64.28%419K85.37%-458K58.11%-1.63M-80.97%349K
Net cash flow
Beginning cash position -15.18%175.6M-31.52%150.86M-61.27%160.61M-17.26%414.65M-50.08%199.71M-74.67%207.04M-61.46%220.31M-17.26%414.65M-15.65%501.14M-22.72%400.09M
Current changes in cash -251.95%-22.04M276.17%24.78M95.38%-8.97M-231.15%-254.63M-382.92%-40.17M98.47%-6.26M-105.70%-14.07M-374.52%-194.13M16.01%-76.89M188.59%14.2M
Effect of exchange rate changes 134.52%367K-105.40%-43K-266.67%-781K106.14%589K193.41%1.07M87.57%-1.06M166.03%797K-4.41%-213K-573.61%-9.6M169.33%364K
End cash Position -22.92%153.93M-15.18%175.6M-31.52%150.86M-61.27%160.61M-61.27%160.61M-50.08%199.71M-74.67%207.04M-61.46%220.31M-17.26%414.65M-17.26%414.65M
Free cash flow -131.92%-47.4M-586.16%-50.08M-11.52%-65.85M-159.30%-121.38M-286.21%-34.6M85.54%-20.44M-103.02%-7.3M-168.88%-59.05M9.98%204.7M171.08%18.58M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data